ADVB advanbiomed.com Final Profit

Corporate emblem and logo of advanbiomed.com (ADVB)

The financial performance dynamics of Advanced Biomed Inc (ADVB) reflect current trends, where the indicator value reaches 0.00. Management at Advanced Biomed Inc is effectively developing microfluidic screening, although scaling operations in the US requires investment. System assembly stability is ensured by strict control of optics suppliers. Technological success is based on robotic blood processing, which automates complex laboratory diagnostics for oncological diseases.

ADVB (Advanced Biomed Corp) Net Profit history from 03/07/2025 to 10/29/2026

Analytical breakdowns and data insights for company advanbiomed.com (ADVB)

- stock value and consensus price forecast:
Market Price Advanced Biomed|ADVB - Price Target Chart
- market capitalization data:
Market Value ADVB|ADVB - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value of a Share Advanced Biomed|ADVB - Book Capitalization|Market Cap to Net Assets Ratio advanbiomed.com|ADVB - Cumulative Company Assets
- debt and solvency information:
Total Debt to Capital Advanced Biomed Inc|ADVB - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Advanced Biomed|ADVB - Company Aggregate Debts|Debts to Book Value ADVB|ADVB - Company Long-Term Debts|Company Short-Term Debts Advanced Biomed|Immediate Liquidity Ratio advanbiomed.com
- net income and valuation multiples indicators:
ADVB - Net Income
Fundamental valuation:ADVB Advanced Biomed Corp
Manufactured product of Advanced Biomed Inc.

This indicator reflects the daily dynamics of net profit, allowing investors to promptly assess the real efficiency of the business without quarterly time lags. By analyzing the operating profit of Advanced Biomed Inc (ADVB), one can track how partnerships in the field of microfluidic chips for cancer diagnostics are being monetized, which serves as a key benchmark for determining the asset's fair market value.

Direct competitors

Company Net Income BeiGene Oncology (ONC)|Company Net Income Halozyme Therapeutics|RVMD: Final Profit|Net Income AAPG (Ascentage Pharma)|CGON (CG Oncology Inc) - Final Profit|Net Profit URGN (UroGen)|BCAX - Net Income|PSNL: Net Income|ERAS - Net Profit|Delcath Systems (DCTH) - Company Net Income|Y-mAbs Therapeutics Inc - Final Profit|AURA (Aura Bio) - Net Profit|Company Net Income Candel CADL|Net Profit ARAY|Net Profit sellaslifesciences.com (SLS)|Net Profit ACTU (Actuate Therapeutics)|CTOR: Company Profit|HURA: Net Income|TARA: Company Net Income|FATE: Net Profit|Aadi Bioscience (WHWK) - Net Profit|Company Net Income TScan Therapeutics Inc|Company Profit CSBR (Champions Oncology Corp)|Net Profit XBIT|Net Income cel-sci.com CVM|Net Profit OSTX (OS Therapies Incorporated)|Radiopharm Theranostics Ltd (RADX) - Company Net Income|Artiva - Net Profit|ANL (Adlai Nortye Ltd.) - Company Profit|VERU (Veru Pharma) - Net Income|Tempest Therapeutics Corp - Final Profit|XLO (Xilio Therapeutics Inc) - Net Profit|Company Net Income RENB|Net Profit MURA|Net Financial Result kairospharma.com|Company Net Income OnKure Therapeutics OKUR|CytoMed Therapeutics Ltd (GDTC) - Company Net Income|CRIS - Company Net Income|Apollomics, Inc. (APLM) - Net Income|THAR: Net Profit|Company Net Income Genprex Inc. (GNPX)|CLDI (Calidi Biotherapeutics Inc.) - Net Profit|Company Profit SBFM (Sunshine Biopharma Inc.)|Net Income XBIO (Xenetic Biosciences)|SLRX (salariuspharma.com) - Final Profit|Net Profit PPBT (Purple Biotech Ltd.)|Net Financial Result American Oncology Network Inc (AONC)|BGNE - Company Net Income|CKPT (Checkpoint Therapeutics Inc) - Company Profit|ELEV: Net Profit|Net Income iCAD|IKNA (Ikena Oncology Inc.) - Net Profit|Net Profit Notable Labs Ltd|Net Profit VIRX|MorphoSys Corporation - Company Profit|NAYA Biosciences - Net Income|ascentage.com - Company Net Income